Skip to main content
SpringerLink
Log in

Mass poisoning with NPS: 2C-E and Bromo-DragonFly

  • Case Report
  • Published:
International Journal of Legal Medicine Aims and scope Submit manuscript

A Correction to this article was published on 21 July 2018

This article has been updated

Abstract

Background

Reports of intoxications with new psychoactive substances (NPS) mostly involve young people, as they are the main consumers of these types of drugs. This report centers on a case that was unusual due to it being a mass-poisoning event involving middle-aged individuals who had consumed a combination of the two different new psychoactive drugs 2,5-dimethoxy-4-ethylphenethylamine (2C-E) and 1-(8-bromofuro[2,3-f][1]benzofuran-4-yl)-2-propanamine (Bromo-DragonFly, BDF).

Case history

The mass poisoning of 29 individuals (24–56 years old) resulted in their admission to six different hospitals with severe symptoms of intoxication. All symptoms manifested after consumption of an unknown drug formulation around lunchtime during an esoteric weekend seminar.

Investigation

Urine (n = 11) and blood samples (n = 29), collected from the 29 individuals for police investigation, were analyzed with immunochemical techniques, GC/MS and LC-MS/MS. 2C-E was confirmed in seven urine samples, but not in blood. BDF was confirmed in all urine samples, and in 17 blood samples. The blood samples exhibited BDF concentrations between ca. 0.6 and ca. 2.0 μg/L, while urine concentrations of BDF ranged from ca. 1.6 to 35 μg/L. The concentration of 2C-E in urine was found to be between ca. 1.5 and 183 μg/L. All patients made a complete recovery, although some had required mechanical ventilation.

Conclusion

The investigation and the presentation of this case illustrates not only mass intoxication with 2C-E and BDF, with corresponding blood and urine concentrations, but also the necessity of collecting urine samples in cases where NPS-consumption is suspected, in order to improve the chances of analytical detection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Change history

  • 21 July 2018

    The original version of this article contains an error. The Author S. Lehmann incorrectly listed as S. Lehman. The correct spelling is presented above. The original article has been corrected.

References

  1. Musselman ME, Hampton JP (2014) “Not for human consumption”: a review of emerging designer drugs. Pharmacotherapy 34:745–757

    Article  PubMed  Google Scholar 

  2. Dean BV, Stellpflug SJ, Burnett AM, Engebretsen KM (2014) 2C or not 2C: phenylethylamine designer drug review. J Med Toxicol 9:172–178

    Article  CAS  Google Scholar 

  3. Shulgin AT, Shulgin A (1991) PIHKAL: a chemical love story. Transform Press, Berkeley

  4. Betäubungsmittelgesetz in der Fassung der Bekanntmachung vom 1. März 1994 (BGBl. I S. 358), das zuletzt durch Artikel 1 der Verordnung vom 16. Juni 2017 (BGBl. I S. 1670) geändert worden ist

  5. Van Vranken MJ, Benavides R, Wians FH (2013) Identification of designer drug 2C-E (4-ethyl-2, 5-dimethoxy-phenethylamine) in urine following a drug overdose. Proc (Bayl Univ Med Cent) 26(1): 58–61B

  6. Topeff JM (2011) The use of intravenous fat emulsion as an adjunct to standard ACLS in the resuscitation of a patient in cardiopulmonary arrest after 2C-E use. Clin Tox 49(6):541

    Google Scholar 

  7. Topeff JM, Ellsworth H, Willhite LA, Bangh SA, Edwards EM, Cole JB (2011) A case series of symptomatic patients, including one fatality, following 2C-E exposure. Clin Tox 49:526

    Google Scholar 

  8. Andreasen MF, Telving R, Birkler RID, Schumacher B, Johannsen M (2009) A fatal poisoning involving Bromo-Dragonfly. Forensic Sci Int 183:91–96

    Article  CAS  PubMed  Google Scholar 

  9. Corazza O, Schifano F, Farre M, Deluca P, Davey Z, Torrens M, Demetrovics Z, Di Furia L, Flesland L, Siemann H, Skutle A, Van Der Kreeft P, Scherbaum N (2011) Designer drugs on the internet: a phenomenon out-of-control? The emergence of hallucinogenic drug Bromo-Dragonfly. Curr Clin Pharmacol 6:125–129

    Article  PubMed  Google Scholar 

  10. Wood DM, Looker JJ, Shaikh L, Button PJM, Davies S, Lidder S, Ramsey J, Holt DW, Dargan PI (2009) Delayed onset of seizures and toxicity associated with recreational use of Bromo-DragonFLY. J Med Toxicol 5:226–229

    Article  PubMed  PubMed Central  Google Scholar 

  11. Parker MA, Marona-Lewicka D, Lucaites VL, Nelson DL, Nichols DE (1998) A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor. J Med Chem 17:5148–5149

    Article  Google Scholar 

  12. Hill SL, Thomas SHL (2011) Clinical toxicology of newer recreational drugs. Clin Tox 49:705–771

    Article  CAS  Google Scholar 

  13. Erowid. http://www.erowid.org

  14. Chambers JJ, Kurrasch-Orbaugh DM, Parker MA, Nichols DE (2001) Enatiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT2A/2C receptor agonists. J Med Chem 44:1003–1010

    Article  CAS  PubMed  Google Scholar 

  15. Neues-psychoaktive-Stoffe-Gesetz (NpSG), 26.11.2016

  16. Maurer HH, Pfleger K, Weber A (2011) Mass spectral library and GC data of drugs, poisons, pesticides, pollutants, and their metabolites. Hoboken, Ney Jersey, USA: Wiley-VCH, GmbH

  17. Rösner P (2012) Mass spectra of designer drugs. Wiley-VCH

  18. Lehmann S, Kieliba T, Beike J, Thevis M, Mercer-Chalmers-Bender K (2017) Determination of 74 new psychoactive substances in serum using automated in-line solid-phase extraction-liquid chromatography-tandem mass spectrometry. J Chromatogr B 1064:124–138

    Article  CAS  Google Scholar 

  19. Peters FT, Hartung M, Herbold M, Schmitt G (2009) Guidelines for quality assurance in forensic-toxicological analyses. Richtlinie der GTFCh zur Qualitätssicherung bei Forensisch Toxikologischen Untersuchungen Anhang B. Toxichem Krimtech 76:185–208

    Google Scholar 

  20. Oregon Public Health Division - Oregon Health Authority (2012) You can’t always get what you want: designer drugs, methemoglobinemia and the internet. CD Summary 61:7 http://healthoregon.org/cdsummary

    Google Scholar 

  21. Thorlacius K, Borna C, Personne M (2008) Bromo-dragon fly-life-threatening drug. Can cause tissue necrosis as demonstrated by the first described case. Lakartidningen 105(16):1199–1200

    PubMed  Google Scholar 

  22. Peronne M, Hulten P (2008) Bromo-Dragonfly, a life threatening designer drug. Clin Toxicol 46:379

  23. Bronstein AC, Spyker DA, Cantilena LR (2010) Annual report of the American Association of Poison Control Centers` National Poison Data System (NPDS: 27th annual report). Clin Tox 48:1175

    Article  Google Scholar 

  24. Haroz R, Greenberg MI (2006) New drugs of abuse in North America. Clin Lab Med 26(147–64):ix

    Google Scholar 

  25. Rohanová M, Pálenícek T, Balíková M (2008) Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration. Toxicol Lett 21;178:29–36

  26. Spiegel D (2017) Das dritte Auge 26:58–60

    Google Scholar 

Download references

Authorship

Shared first authorship: Iwersen-Bergmann S, Lehman S. Shared last authorship: Vidal C, Mercer-Chalmers-Bender K.

Author information

Authors and Affiliations

  1. Department of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    S. Iwersen-Bergmann, A. Heinemann, C. Schröder, A. Müller, H. Jungen, H. Andresen-Streichert & K. Pueschel

  2. Institute of Legal Medicine, University Hospital of Cologne, Cologne, Germany

    S. Lehmann, H. Andresen-Streichert & K. Mercer-Chalmers-Bender

  3. Forensic Science Institute, State Criminal Police Office of Lower Saxony, Hannover, Germany

    C. Vidal

  4. Health Department Basel, Institute of Forensic Medicine, University of Basel, Basel, Switzerland

    K. Mercer-Chalmers-Bender

Authors
  1. S. Iwersen-Bergmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Lehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Heinemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Schröder
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Jungen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Andresen-Streichert
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K. Pueschel
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C. Vidal
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. K. Mercer-Chalmers-Bender
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Iwersen-Bergmann.

Additional information

The original version of this article was revised: The Author S. Lehmann incorrectly listed as S. Lehman. The correct spelling is presented above.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iwersen-Bergmann, S., Lehmann, S., Heinemann, A. et al. Mass poisoning with NPS: 2C-E and Bromo-DragonFly. Int J Legal Med 133, 123–129 (2019). https://doi.org/10.1007/s00414-018-1882-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00414-018-1882-9

Keywords

Search

Navigation